What is the use of Finasteride (Propecia)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: April 15, 2025 • View editorial policy

From the Guidelines

Finasteride is recommended as a treatment option for benign prostatic hyperplasia (BPH) in patients with an enlarged prostate, as it has been shown to reduce prostate size and improve urinary symptoms, with a mean change in IPSS of -4.74 points 1.

Key Points

  • Finasteride works by inhibiting the enzyme 5-alpha-reductase, which converts testosterone to dihydrotestosterone (DHT), a hormone that contributes to prostate enlargement.
  • The medication is typically prescribed as a 5mg daily oral tablet for prostate issues, and treatment requires continuous use for at least 3-6 months before results become noticeable.
  • Common side effects include decreased libido, erectile dysfunction, and decreased ejaculate volume, which may persist even after discontinuation in some cases.
  • Regular follow-up with a healthcare provider is important to monitor for side effects and effectiveness.
  • The most recent and highest quality study, published in 2021, supports the use of finasteride as a treatment option for BPH, with a moderate recommendation and evidence level of Grade C 1. ### Considerations
  • Patients should be informed of alterations in PSA due to the medication, and the measured serum PSA value should be doubled after 1 year of 5-ARI therapy to accurately gauge disease progression.
  • Treatment with 5-ARIs and combination therapy hinges on prostate volume and PSA threshold, and obtaining imaging with TRUS to objectively assess prostate size is reasonable.
  • The larger the gland, the more pronounced the effects of finasteride, and a minimum prostate volume of >30cc or PSA >1.5ng/mL is necessary for a reliable 5-ARI response.

From the FDA Drug Label

The development and enlargement of the prostate gland is dependent on the potent androgen, 5α -dihydrotestosterone (DHT). Finasteride is a competitive and specific inhibitor of Type II 5α-reductase with which it slowly forms a stable enzyme complex. In man, a single 5-mg oral dose of finasteride tablets produces a rapid reduction in serum DHT concentration, with the maximum effect observed 8 hours after the first dose.

Finasteride Mechanism of Action: Finasteride works by inhibiting the enzyme Type II 5α-reductase, which converts testosterone to dihydrotestosterone (DHT).

  • It forms a stable enzyme complex with Type II 5α-reductase, leading to a decrease in DHT levels.
  • The reduction in DHT levels leads to a decrease in the development and enlargement of the prostate gland.
  • The maximum effect of finasteride on serum DHT concentration is observed 8 hours after the first dose 2.

From the Research

Finasteride Overview

  • Finasteride is primarily used to treat benign prostatic hyperplasia (BPH) and male androgenetic alopecia (MAA) 3.
  • It is a 5-alpha reductase inhibitor (5α-RI) that can induce male sexual dysfunction due to its effects on testosterone and dihydrotestosterone 3.

Side Effects of Finasteride

  • There is evidence suggesting that 5α-RIs may independently increase the risk of erectile dysfunction (ED) 3.
  • Finasteride has been correlated with ED in patients with BPH, but not in patients with MAA 3.
  • Some studies have reported side effects of finasteride associated with sexual dysfunction, including ED, male infertility, ejaculation problems, and loss of libido, even in MAA patients 3, 4.
  • Long-term use of finasteride may be associated with health risks including non-alcoholic fatty liver disease (NAFLD), insulin resistance (IR), type 2 diabetes (T2DM), dry eye disease, and potential kidney disease 5.

Efficacy of Finasteride

  • Finasteride 1 mg/day has been shown to significantly increase total hair count compared to placebo after 24 and 48 weeks 4.
  • The efficacy of finasteride has been demonstrated in clinical trials, with pairwise and network meta-analyses performed to assess its efficacy 4.
  • A novel composition using naturally derived 5AR inhibitors has been shown to outperform finasteride in in vitro assays of representative cell lines for AGA and BPH 6.

Patient Education and Awareness

  • Patients need to be educated about the possible short- and long-term side effects of finasteride 4.
  • Physicians should discuss with their patients the possible long-term effects of finasteride on sexual function 3.
  • Factors that may explain finasteride's inconsistency regarding its therapeutic and side effects should be further investigated and used to categorize subjects into distinct subgroups 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.